80 related articles for article (PubMed ID: 8712752)
1. Hypermethylation of the myogenic gene Myf-3 in human breast carcinomas.
Hähnel R; Harvey J; Kay P
Anticancer Res; 1996; 16(4A):2111-5. PubMed ID: 8712752
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the Myf-3 gene in human colorectal cancer.
Iacopetta BJ; Harmon D; Spagnolo DV; House AK; Kay PH
Anticancer Res; 1997; 17(1A):429-32. PubMed ID: 9066689
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of HpaII recognition sequences within the 5' coding region of the estrogen receptor gene is not associated with estrogen receptor negativity in primary breast tumours.
Kay PH; Hähnel R; Gunn H; Harmon D; Song J
Anticancer Res; 1998; 18(3A):1709-12. PubMed ID: 9673394
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.
Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ
Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
7. Evidence that DNA methylation imbalance is not involved in the development of malignant mesothelioma.
Bagwe AN; Kay PH; Spagnolo DV
Anticancer Res; 1997; 17(5A):3341-3. PubMed ID: 9413169
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
9. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
10. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients.
de Bock GH; Tollenaar RA; Papelard H; Cornelisse CJ; Devilee P; van de Vijver MJ
Br J Cancer; 2001 Nov; 85(9):1347-50. PubMed ID: 11720473
[TBL] [Abstract][Full Text] [Related]
13. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers.
Wang Q; Driouch K; Courtois S; Champème MH; Bièche I; Treilleux I; Briffod M; Rimokh R; Magaud JP; Curmi P; Lidereau R; Puisieux A
Oncogene; 1998 Feb; 16(5):677-9. PubMed ID: 9482115
[TBL] [Abstract][Full Text] [Related]
15. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique.
Huang TH; Laux DE; Hamlin BC; Tran P; Tran H; Lubahn DB
Cancer Res; 1997 Mar; 57(6):1030-4. PubMed ID: 9067264
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of the methylation status of Myf-3 in lymphoproliferative disorders.
Taylor JM; Kay PH; Spagnolo DV
Methods Mol Med; 2004; 97():251-65. PubMed ID: 15064498
[No Abstract] [Full Text] [Related]
17. DNA hypermethylation in breast cancer and its association with clinicopathological features.
Li S; Rong M; Iacopetta B
Cancer Lett; 2006 Jun; 237(2):272-80. PubMed ID: 16029926
[TBL] [Abstract][Full Text] [Related]
18. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms.
Lien HC; Lu YS; Cheng AL; Chang WC; Jeng YM; Kuo YH; Huang CS; Chang KJ; Yao YT
J Pathol; 2006 Jul; 209(3):317-27. PubMed ID: 16639692
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer.
Fujii H; Biel MA; Zhou W; Weitzman SA; Baylin SB; Gabrielson E
Oncogene; 1998 Apr; 16(16):2159-64. PubMed ID: 9572497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
